Anti-Phospholipid Screen

The combined detection of four “phospholipid antibodies” lends this test particularly high clinical sensitivity. ORGENTEC’s test systems for the isolated detection of the individual phospholipid autoantibodies, the Anti-beta-2-glyoprotein-I test, or the ThromboCombo ELISA can subsequently be used for the differentiated quantitative determination of the autoantibodies.

Anti-Phospholipid Screen IgG

Anti-Phospholipid Screen IgG is an ELISA-based screening test for the quantitative determination of IgG antibodies against cardiolipin, phosphatidyl serine, phosphatidyl inositol, phosphatidic acid, and cofactor beta-2-glycoprotein I in human serum or plasma. This test is an outstanding tool for the serological detection of primary and secondary antiphospholipid syndrome.

Specifications

Product Number	ORG 229G
Tests	24 Alegria^® strips
Calibration	Harris sera, IRP 97/656 (IgG), HCAL (IgG) / EY2C9 (IgM)
Calculation	quantitative
Range	0 - 100 GPL-U/ml
Cut-off	10 GPL-U/ml
Coating	cardiolipin (cofactor: beta-2-GPI), phosphatidic acid, phosphatidyl inositol, phosphatidyl serine

Alegria

ORG 215A ORG 215G ORG 215M ORG 215S ORG 237G ORG 237M ORG 236G ORG 236M ORG 235G ORG 235M

ELISA

ORG 515 ORG 515A ORG 515S ORG 529 ORG 537 ORG 536 ORG 535

Documentation

Instruction for Use

Document Archive

Instruction for Use Revision 4. Earlier versions and additional languages can be found in the document archive.

Anti-Phospholipid Screen IgM

Anti-Phospholipid Screen IgM is an ELISA-based screening test for the quantitative determination of IgM antibodies against cardiolipin, phosphatidyl serine, phosphatidyl inositol, phosphatidic acid, and cofactor beta-2-glycoprotein I in human serum or plasma. This test is an outstanding tool for the serological detection of primary and secondary antiphospholipid syndrome.